Poly Medicure Ltd

Poly Medicure Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Poly Medicure Ltd

₹ 1,563 -0.63%
19 Jun - close price
polymedicure.com BSE: 531768 NSE: POLYMED
About

Poly Medicure Limited is an India-based manufacturer and exporter of medical devices. The Company exports plastic medical disposables/surgical devices.[1]

Key Points

Product Portfolio:[1]
PML is a medical devices company
with a product portfolio comprised of
200+ SKUs of medical devices across
12 specialties including therapy, oncology, anesthesia and respiratory care, urology, gastroenterology, blood management and
blood collection, surgery and wound drainage, dialysis, central venous access catheters, veterinary medical devices, and others.

Website BSE NSE
  • Market Cap ₹ 15,846 Cr.
  • Current Price ₹ 1,563
  • High / Low ₹ 2,318 / 1,182
  • Stock P/E 46.5
  • Book Value ₹ 301
  • Dividend Yield 0.22 %
  • ROCE 15.0 %
  • ROE 11.8 %
  • Face Value ₹ 5.00
Edit ratios

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 21.5% CAGR over last 5 years

Cons

  • Company has a low return on equity of 13.8% over last 3 years.
  • Working capital days have increased from 128 days to 259 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies

Part of BSE 500 BSE Healthcare Nifty 500 BSE 250 SmallCap Index BSE 400 MidSmallCap Index

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
293 306 320 321 361 367 402 411 421 384 417 419 443
212 220 237 236 264 266 290 295 305 283 305 307 322
Operating Profit 82 85 83 84 97 101 113 115 116 101 111 112 121
OPM % 28% 28% 26% 26% 27% 28% 28% 28% 28% 26% 27% 27% 27%
9 13 13 17 16 17 27 22 24 42 34 23 15
Interest 2 2 2 3 3 3 3 3 2 3 3 4 4
Depreciation 15 15 15 16 16 19 20 21 21 23 24 25 26
Profit before tax 73 81 78 82 94 96 117 113 116 117 118 106 107
Tax % 22% 25% 24% 25% 25% 25% 25% 25% 26% 25% 25% 26% 25%
57 61 59 61 71 72 87 85 87 88 89 78 81
EPS in Rs 5.99 6.31 6.17 6.41 7.35 7.53 8.61 8.40 8.55 8.68 8.79 7.73 7.95
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
373 393 439 507 586 646 746 879 1,068 1,306 1,601 1,662
288 307 345 386 452 483 536 665 801 954 1,153 1,216
Operating Profit 85 86 94 122 134 162 210 214 266 352 448 446
OPM % 23% 22% 21% 24% 23% 25% 28% 24% 25% 27% 28% 27%
28 8 13 14 16 19 19 39 36 57 89 113
Interest 10 10 8 11 13 20 10 5 10 13 14 13
Depreciation 18 20 23 28 36 39 46 53 56 62 81 98
Profit before tax 84 65 76 96 100 122 173 195 237 335 443 448
Tax % 27% 27% 26% 27% 34% 24% 25% 25% 24% 25% 25% 25%
61 47 56 70 66 92 130 146 179 252 331 336
EPS in Rs 6.92 5.36 6.37 7.96 7.51 10.47 13.51 15.23 18.66 26.23 32.70 33.15
Dividend Payout % 18% 28% 39% 25% 27% 19% 19% 16% 16% 11% 11% 11%
Compounded Sales Growth
10 Years: 16%
5 Years: 17%
3 Years: 16%
TTM: 4%
Compounded Profit Growth
10 Years: 22%
5 Years: 22%
3 Years: 26%
TTM: 14%
Stock Price CAGR
10 Years: 23%
5 Years: 10%
3 Years: 11%
1 Year: -24%
Return on Equity
10 Years: 15%
5 Years: 14%
3 Years: 14%
Last Year: 12%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 22 22 44 44 44 44 48 48 48 48 51 51
Reserves 170 202 225 290 336 385 906 1,029 1,186 1,410 2,694 3,002
76 79 97 127 150 194 126 111 137 164 172 252
87 73 83 93 103 117 107 146 167 199 224 246
Total Liabilities 354 376 449 555 633 740 1,187 1,334 1,538 1,821 3,140 3,550
161 177 201 260 272 328 389 451 598 831 1,047 1,223
CWIP 10 14 20 18 19 25 21 43 78 71 93 90
Investments 6 6 6 18 42 58 385 384 181 221 1,127 1,243
178 180 222 258 300 330 392 456 681 699 873 994
Total Assets 354 376 449 555 633 740 1,187 1,334 1,538 1,821 3,140 3,550

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
63 62 55 76 113 127 116 126 197 256 237 245
-57 -30 -54 -87 -104 -106 -434 -89 -189 -237 -1,191 -268
-9 -31 -1 14 -10 -22 319 -40 -8 -17 953 28
Net Cash Flow -2 1 0 3 -1 -1 1 -2 -0 2 -2 5
Free Cash Flow 15 30 0 -6 68 23 23 -24 -40 -13 -87 -49
CFO/OP 102% 88% 78% 81% 105% 100% 76% 81% 96% 94% 73% 77%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 58 75 79 81 77 68 73 80 76 72 78 97
Inventory Days 146 105 193 207 138 241 202 210 222 194 215 194
Days Payable 103 77 136 130 93 144 104 109 95 89 66 58
Cash Conversion Cycle 101 103 136 157 123 165 171 181 203 177 226 232
Working Capital Days 24 36 58 74 58 45 73 80 65 52 73 259
ROCE % 30% 26% 25% 26% 23% 25% 21% 16% 19% 22% 18% 15%

Insights

In beta
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Number of Countries Exported To
Count

Log in to view insights

Please log in to see hidden values.

Login
Number of SKUs / Product Categories
Count
Patents Granted (Cumulative)
Count
Domestic Revenue Contribution
%
R&D Expenditure (Percentage of Turnover)
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
53.32% 53.17% 53.17% 53.14% 66.02% 62.56% 62.44% 62.44% 62.44% 62.42% 62.42% 62.42%
15.61% 14.49% 14.10% 12.37% 9.91% 11.88% 12.33% 11.46% 11.41% 9.77% 9.41% 5.92%
4.25% 5.15% 5.46% 7.21% 9.34% 12.33% 11.66% 11.96% 11.72% 13.53% 13.84% 15.60%
26.82% 27.20% 27.28% 27.25% 14.72% 13.23% 13.57% 14.13% 14.43% 14.28% 14.34% 16.08%
No. of Shareholders 36,14134,64936,05336,71236,85238,35260,68665,58371,14264,40067,75073,414

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls